For the year ending 2025-12-31, IBO made $32K in revenue. -$11,838K in net income. Net profit margin of -36993.75%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 32 | |||
| Cost of revenue | 424 | |||
| Sales, general and administrative compensation (inclusive of stock-based compensation) | 873 | |||
| Sales and marketing | 24 | |||
| Professional fees | 1,005 | |||
| Research and development | 340 | |||
| Depreciation and amortization | 1,145 | |||
| Rent and utilities | 74 | |||
| Loss on disposal of fixed assets | -12 | |||
| Other operating expenses | 417 | |||
| Total costs and expenses | 4,314 | |||
| Operating loss | -4,282 | |||
| Interest income | 13 | |||
| Change in fair value of note payable, related party | 9,388 | |||
| Interest expense | 793 | |||
| Loss from operations before income taxes | -14,450 | |||
| Income tax benefit (expense) | -2,580 | |||
| Net loss | -11,870 | |||
| Loss from operations attributed to noncontrolling interest | -32 | |||
| Net loss attributable to common stockholders | -11,838 | |||
| Basic EPS | -0.38 | |||
| Diluted EPS | -0.38 | |||
| Basic Average Shares | 31,550,457 | |||
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)